Literature DB >> 22893309

Deferasirox and renal dysfunction in children.

Sunil Bhandari1, Shahina Daar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22893309     DOI： 10.1007/s00467-012-2226-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  2 in total

1.  Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.

Authors:  Manuela Balocco; Paola Carrara; Valeria Pinto; Gian Luca Forni
Journal:  Am J Hematol       Date:  2010-06       Impact factor: 10.047

2.  Deferasirox-induced renal impairment in children: an increasing concern for pediatricians.

Authors:  Laurence Dubourg; Céline Laurain; Bruno Ranchin; Corinne Pondarré; Aoumeur Hadj-Aïssa; Dominique Sigaudo-Roussel; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2012-04-24       Impact factor: 3.714
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.